Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
2,2',2''-((1R,5S,8S,12S,16S,20S,23R,26S,29S,32S,35S,38S,41S)-26,41-dibenzyl-32-sec-butyl-8,16-bis(3-guanidinopropyl)-35-(hydroxymethyl)-5,20-di(naphthalen-1-yl)-3,7,10,13,15,18,22,25,28,31,34,37,40,43-tetradecaoxo-45,46-dithia-2,6,9,11,14,17,21,24,27,30,33,36,39,42-tetradecaazabicyclo[21.20.4]heptatetracontane-12,29,38-triyl)triacetic acid
ID: ALA4876757
PubChem CID: 164625760
Max Phase: Preclinical
Molecular Formula: C84H104N20O21S2
Molecular Weight: 1794.01
Molecule Type: Unknown
Associated Items: